Sunday - December 22, 2024

Aryl, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- ACHILLION PHARMACEUTICALS, INC., Boston, Massachusetts has been assigned a patent (No. US 12162860 B2, initially filed May 11, 2023) developed by thirteen inventors Jason Allan Wiles, Madison, Connecticut; Avinash S. Phadke, Branford, Connecticut; Milind Deshpande, Madison, Connecticut; Atul Agarwal, Hamden, Connecticut; Dawei Chen, Guilford, Connecticut; Venkat Rao gadhachanda, Hamden, Connecticut; Akihiro Hashimoto, Branford, Connecticut; Godwin Pais, Hamden, C . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Aryl, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders

Information Request Form

Copyright Targeted News Service 2024